# Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan

> **NCT04268524** · PHASE3 · RECRUITING · sponsor: **Medecins Sans Frontieres, Netherlands** · enrollment: 832 (estimated)

## Conditions studied

- Old World Cutaneous Leishmaniasis

## Interventions

- **COMBINATION_PRODUCT:** drug: miltefosine with thermotherapy

## Key facts

- **NCT ID:** NCT04268524
- **Lead sponsor:** Medecins Sans Frontieres, Netherlands
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-07
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 832 (ESTIMATED)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04268524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04268524, "Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04268524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*